Abacus CEO explains why young Canadians value DB pensions more than homeownership
Read BPM's highlighted coverage of key topics from June
Markets may be underpricing CUSMA risk for institutional investors, experts warn
GreenShield’s Dr. Khush Amaria explains why young men disengage from mental health care, where benefits stand, and what plan sponsors can do
Medical director at Phoenix and Raven explains why brand-name Ozempic still leads despite Health Canada approvals
The authorization could ease cost pressures on group benefit plan sponsors covering GLP-1 drugs
Experts weigh in on what SpaceX reveals about the private market gap for pensions
Gross assets under management for the BC-based pension fund grew to $313.7 billion from $295 billion the prior year
Canada Life’s national practice leader highlights what’s next for Canadian plan sustainability
Normandin Beaudry, GreenShield make the business case for inclusive benefit plans